| [1] |
Connor JR, Ponnuru P, Lee BY, et al. Postmortem and imaging based analyses reveal cns decreased myelination in restless legs syndrome[J]. Sleep Med, 2011, 12(6):614-619.
|
| [2] |
Celle S, Roche F, Peyron R, et al. Lack of specific gray matter alterations in restlesslegs syndrome in elderly subjects[J]. J Neurol, 2010, 257(3):344-348.
|
| [3] |
Belke M, Heverhagen JT, Keil B, et al. DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome[J]. Brain Behav, 2015, 5(9):e00327.
|
| [4] |
Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report[J]. Sleep Med, 2018, 41, 27-44.
|
| [5] |
Krieger J, Schroeder C. Iron, brain and restless legs syndrome[J]. Sleep Med Rev, 2001, 5(4):277-286.
|
| [6] |
Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications[J]. Gastroenterol Clin North Am, 2018, 47(4):727-739.
|
| [7] |
Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric ner-vous system[J]. Gut, 2000, 47(Suppl 4):iv15-9, discussion iv26.
|
| [8] |
Gershon MD. Developmental determinants of the independence and complexity of the enteric nervous system[J]. Trends Neurosci, 2010, 33(10):446-456.
|
| [9] |
Smith PA. The tantalizing links between gut microbes and the brain[J]. Nature, 2015, 526(7573):312-314.
|
| [10] |
Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease?[J]. Gastroenterology, 2005, 128(4 Suppl.1):S47-51.
|
| [11] |
Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study[J]. Arch Intern Med, 2003, 163(3):286-292.
|
| [12] |
Fasano A. Celiac disease-how to handle a clinical chameleon[J]. N Engl J Med, 2003, 348(25):2568-2570.
|
| [13] |
Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment[J]. J Clin Gastroenterol, 2006, 40(1):3-14.
|
| [14] |
Green PH, Cellier C. Celiac disease[J]. N Engl J Med, 2007, 357(17):1731-1743.
|
| [15] |
Weinstock LB, Walters AS, Mullin GE, et al. Celiac disease is associated with restless legs syndrome[J]. Dig Dis Sci, 2010, 55(6):1667-1673.
|
| [16] |
Manchanda S, Davies CR, Picchietti D. Celiac disease as a possible cause for low serum ferritin in patients with restless legs syndrome[J]. Sleep Med, 2009, 10(7):763-765.
|
| [17] |
Uygur-Bayramicli O, Ozel AM. Celiac disease is associated with neurological syndromes[J]. Dig Dis Sci, 2011, 56(5):1587-1588.
|
| [18] |
Banno K, Delaive K, Walld R, et al. Restless legs syndrome in 218 patients: associated disorders[J]. Sleep Med, 2000, 1(3):221-229.
|
| [19] |
Salih AM, Gray RE, Mills KR, et al. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis[J]. Br J Rheumatol, 1994, 33(1):60-63.
|
| [20] |
Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study[J]. BMJ, 1996, 312(7042):1339.
|
| [21] |
Bellini M, Gambaccini D, Stasi C, et al. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy[J]. World J Gastroenterol, 2014, 20(27):8807-8820.
|
| [22] |
Tanaka Y, Kanazawa M, Fukudo S, et al. Biopsychosocial model of irritable bowel syndrome[J]. J Neurogastroenterol Motil, 2011, 17(2):131-139.
|
| [23] |
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review[J]. JAMA, 2015, 313(9):949-958.
|
| [24] |
Padhy SK, Sahoo S, Mahajan S, et al. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel" ?[J]. J Neurosci Rural Pract, 2015, 6(4):568-577.
|
| [25] |
Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lac-tulose breath testing[J]. Ann Rheum Dis, 2004, 63(4):450-452.
|
| [26] |
Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome[J]. Annu Rev Med, 2001, 52:319-338.
|
| [27] |
Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial over-growth[J]. Sleep Med, 2011, 12(6):610-613.
|
| [28] |
Borji R, Fereshtehnejad SM, Taba Taba Vakili S, et al. Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group[J]. J Neurogastroenterol Motil, 2012, 18:426-433.
|
| [29] |
Basu PP, Shah NJ, Krishnaswamy N, et al. Prevalence of rest-less legs syndrome in patients with irritable bowel syndrome[J]. World J Gastroenterol, 2011, 17(39):4404-4407.
|
| [30] |
Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology[J]. Lancet, 2007, 369:1627-1640.
|
| [31] |
Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review[J]. Aliment Pharmacol Ther, 2002, 16:51-60.
|
| [32] |
Shanahan F. Crohn's disease[J]. Lancet, 2002, 359(9300):62-69.
|
| [33] |
Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies[J]. Lancet, 2007, 369(9573):1641-1657.
|
| [34] |
Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases[J]. World J Gastroenterol, 2006, 12(30):4819-4831.
|
| [35] |
Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease[J]. Aliment Pharmacol Ther, 2006, 24(11-12):1507-1523.
|
| [36] |
Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease[J]. Am J Gastroenterol, 2008, 103(5):1299-1307.
|
| [37] |
Balfour Sartor R. Bacteria in Crohn’s disease: mechanisms of inflammation and therapeutic implications[J]. J Clin Gastroenterol, 2007, 41(suppl 1):S37-S43.
|
| [38] |
Biancone L, Vernia P, Agostini D, et al. Effect of rifaximin on intestinal bacterial overgrowth in Crohn’s disease as assessed by the H2-Glucose Breath Test[J]. Curr Med Res Opin, 2000, 16(1):14-20.
|
| [39] |
Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn’s disease[J]. Curr Med Res Opin, 2005, 21(8):1165-1169.
|
| [40] |
Weinstock LB, Bosworth BP, Scherl EJ, et al. Crohn’s disease is associated with restless legs syndrome[J]. Inflamm Bowel Dis, 2010, 16(2):275-279.
|
| [41] |
Hoek PD, Smits MG, de Roos NM, et al. Increased prevalence of restless legs syndrome in patients with Crohn’s disease[J]. Eur J Gastroenterol Hepatol, 2015, 27(8):951-955.
|